M&A Deal Summary

Huadong Medicine Acquires Sinclair Pharmaceuticals

On November 19, 2018, Huadong Medicine acquired life science company Sinclair Pharmaceuticals for 222M USD

Acquisition Highlights
  • This is Huadong Medicine’s 1st transaction in the Life Science sector.
  • This is Huadong Medicine’s largest (disclosed) transaction.
  • This is Huadong Medicine’s 1st transaction in the United Kingdom.

M&A Deal Summary
Date 2018-11-19
Target Sinclair Pharmaceuticals
Sector Life Science
Buyer(s) Huadong Medicine
Deal Type Add-on Acquisition
Deal Value 222M USD

Target

Sinclair Pharmaceuticals

London, United Kingdom
Sinclair Pharmaceuticals Ltd. is an international specialty pharma company, with corporate headquarters in London, UK, and operations headquarters in Paris, France.

Search 201,292 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Huadong Medicine

Hangzhou, China
Category Company
Founded 1993
Sector Medical Products
DESCRIPTION

Huadong Medicine Co. Ltd. is a manufacturer and distributor of pharmaceutical and medical products in China.

DEAL STATS #
Overall 1 of 2
Sector (Life Science) 1 of 1
Type (Add-on Acquisition) 1 of 1
Country (United Kingdom) 1 of 1
Year (2018) 1 of 1
Size (of disclosed) 1 of 1
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2019-06-13 R2 Dermatology

San Ramon, California, United States

R2 Dermatology is a developer of medical devices for the treatment of aesthetic and medical skin conditions, including a skin lightening and skin-tone evening product utilizing “cold technology”. R2 Dermatology was formed in 2014 and is based in San Ramon, California.

Buy -
Mergr

Product

Company

Legal